ESC Premium Access

Nephro-protective effects of Dapagliflozin in patients with type 2 diabetes

Congress Presentation

About the speaker

Doctor Masafumi Nakayama

Tokyo D Tower Hospital, Tokyo (Japan)
0 follower

7 more presentations in this session

Excess risk of heart failure among persons with type 2 diabetes

Speaker: Professor A. Rosengren (Gothenburg, SE)


Efficacy and safety of didpeptidyl peptidase 4 inhibitors and sodium-glucose linked cotransporter-2 inhibitors in patients with type 2 diabetes mellitus: a meta-analysis

Speaker: Doctor G. Savarese (Stockholm, SE)


Impact of pioglitazone on cardiovascular events in patients with type-II diabetes mellitus after drug-eluting stent implantation

Speaker: Doctor H. Yokoi (Fukuoka, JP)


Histone 3 lysine 27 trimethylation in type 2 diabetes: a novel potential pharmacological target in diabetic foot ulcer treatment

Speaker: Doctor M. Colognesi-Capogrossi (Rome, IT)


Impact of the presence and treatment status of diabetes on long-term mortality following coronary angiography

Speaker: Doctor B. Zafrir (Haifa, IL)


Access the full session

Improving diabetes outcomes: beyond glucocentricity

Speakers: Doctor M. Nakayama, Professor A. Rosengren, Doctor G. Savarese, Doctor H. Yokoi, Doctor M. Colognesi-Capogrossi...

About the event


ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

ESC 365 is supported by